Picture of blood cells

Open Access research which pushes advances in bionanotechnology

Strathprints makes available scholarly Open Access content by researchers in the Strathclyde Institute of Pharmacy & Biomedical Sciences (SIPBS) , based within the Faculty of Science.

SIPBS is a major research centre in Scotland focusing on 'new medicines', 'better medicines' and 'better use of medicines'. This includes the exploration of nanoparticles and nanomedicines within the wider research agenda of bionanotechnology, in which the tools of nanotechnology are applied to solve biological problems. At SIPBS multidisciplinary approaches are also pursued to improve bioscience understanding of novel therapeutic targets with the aim of developing therapeutic interventions and the investigation, development and manufacture of drug substances and products.

Explore the Open Access research of SIPBS. Or explore all of Strathclyde's Open Access research...

Management of ataxias : guidelines on best clinical practice

De Silva, R and Giunti, P and Fletcher, N and Hadjivassiliou, M and Harrison, E and Hunt, B and Lowit, Anja and Morrison, P and Robertson, N and Schapira, T and Surtees, R and Talbot, K (2007) Management of ataxias : guidelines on best clinical practice. Ataxia UK, London.

Full text not available in this repository.Request a copy from the Strathclyde author

Abstract

This document aims to provide recommendations for healthcare professionals on the diagnosis and management of people with ataxia. Ataxia means ‘lack of coordination’ and it is a symptom of many conditions. These guidelines focus on the progressive ataxias, and exclude disorders where ataxia is an epiphenomenon of another neurological condition (see Table 1). Certain aspects of these Guidelines may however be relevant to these other conditions. They have been developed through extensive consultation with ataxia specialist neurologists and other healthcare professionals in collaboration with the patient support organisation, Ataxia UK.